Comparison between Fabino Life Sciences IPO and Safa Systems IPO.
Fabino Life Sciences IPO is a SME Fixed Price IPO proposed to list at BSE SME while Safa Systems IPO is a SME Fixed Price proposed to list at BSE SME.
| Fabino Life Sciences IPO | Safa Systems IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Aryaman Financial Services Ltd. | Finshore Management Services Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Cameo Corporate Services Ltd. |
| Market Maker | Aryaman Capital Markets Ltd. | Nikunj Stock Brokers Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Fabino Life Sciences IPO is up to ₹3.07 Cr whereas the issue size of the Safa Systems IPO is up to ₹3.80 Cr. The final issue price of Fabino Life Sciences IPO is ₹36.00 per share and of Safa Systems IPO is ₹10.00 per share.
| Fabino Life Sciences IPO | Safa Systems IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹36.00 per share | ₹10.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 3000 shares | 10000 shares |
| Fresh Issue Size | 8,52,000 shares | 38,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹3.07 Cr | up to ₹3.80 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 8,52,000 shares | 38,00,000 shares |
| Issue Size Total (Amount) | up to ₹3.07 Cr | up to ₹3.80 Cr |
Fabino Life Sciences IPO opens on Dec 31, 2021, while Safa Systems IPO opens on Jan 28, 2022. The closing date of Fabino Life Sciences IPO and Safa Systems IPO is Jan 05, 2022, and Feb 01, 2022, respectively.
| Fabino Life Sciences IPO | Safa Systems IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Dec 31, 2021 | Jan 28, 2022 |
| Issue Close | Jan 05, 2022 | Feb 01, 2022 |
| Basis Of Allotment (Tentative) | Jan 10, 2022 | Feb 04, 2022 |
| Initiation of Refunds (Tentative) | Jan 11, 2022 | Feb 07, 2022 |
| Credit of Share (Tentative) | Jan 12, 2022 | Feb 08, 2022 |
| Listing date (Tentative) | Jan 13, 2022 | Feb 09, 2022 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Fabino Life Sciences IPO P/E ratio is 133, as compared to Safa Systems IPO P/E ratio of 29.41.
| Fabino Life Sciences IPO | Safa Systems IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 99.43 | 100 | ||||
| Promoter Shareholding (Post-Issue) | 56.82 | 73.47 | ||||
| P/E Ratio | 133 | 29.41 | ||||
| Market Cap | ₹7.56 Cr. | ₹15.08 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 3.48 |
In the Fabino Life Sciences IPO Retail Individual Investors (RII) are offered 4,26,000 shares while in Safa Systems IPO retail investors are offered 4,26,000 shares. Qualified Institutional Buyers (QIB) are offered in Fabino Life Sciences IPO and in Safa Systems IPO.
| Fabino Life Sciences IPO | Safa Systems IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 48,000 shares | 2,00,000 shares |
| QIB | ||
| NII | 4,26,000 shares | 19,00,000 shares |
| RII | 4,26,000 shares | 19,00,000 shares |
| Employee | ||
| Others | ||
| Total | 8,52,000 shares | 38,00,000 shares |
Fabino Life Sciences IPO subscribed 6.93x in total, whereas Safa Systems IPO subscribed 52.71x.
| Fabino Life Sciences IPO | Safa Systems IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 3.49x | 64.61x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 10.36x | 40.81x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 6.93x | 52.71x |
